Nolan S P, Crampton R S, McGuire L B, McGann R C, Holz H C, Muller W H
Ann Surg. 1977 Jan;185(1):122-7. doi: 10.1097/00000658-197701000-00020.
With the advent of permanent cardiac pacing, technology has produced power sources that will last two, four, and even 20 years. The cost of these devices is proportional to their complexity and expected life. Therefore, the selection of an appropriate pulse generator should be based on the patient's prognosis. An actuarial analysis of 319 consecutive patients receiving permanent cardiac pacemakers was performed in order to determine whether prepacing factors influenced prognosis. The survival probability at 5 years was not influenced by sex, race, type of conduction defect, or antecedent disease. Survival rate decreased only slightly for each decade of life, but even in the ninth decade there was an acceptable prognosis.
随着永久性心脏起搏技术的出现,技术已经生产出能够持续使用2年、4年甚至20年的电源。这些设备的成本与其复杂性和预期寿命成正比。因此,合适脉冲发生器的选择应基于患者的预后。为了确定起搏前因素是否影响预后,对319例连续接受永久性心脏起搏器治疗的患者进行了精算分析。5年时的生存概率不受性别、种族、传导缺陷类型或既往疾病的影响。每增长十岁生存率仅略有下降,但即使在九十岁时仍有可接受的预后。